A combination story can describe a real improvement without showing which component caused it. Adding ARA-290 to another peptide product, device or supplement regimen creates a new research question; it does not inherit an answer from a trial of ARA-290 in a different setting.
What a controlled trial tries to isolate
In the sarcoidosis pilot, participants were assigned to active study treatment or matching placebo while background clinical care was documented. That comparison is different from starting several interventions and attributing the change to the newest ingredient.
Even a controlled result has limits. It applies to the studied intervention and accompanying care, not every possible combination available elsewhere.
Why the sequence is not enough
Suppose symptoms improve after a device, a compound and an activity change begin close together. The timing does not identify which change mattered, whether several interacted or whether the condition changed independently. A strong personal conviction cannot resolve variables the observation did not separate.
This is also why an additional ingredient cannot be credited merely because improvement followed its introduction. Effects from earlier care and changing expectations may still be relevant. These are competing explanations, not a dismissal of the person's experience.
What would establish an added contribution
A useful study would compare the same background intervention with and without the added agent, using a characterized preparation and prespecified outcomes. It would need to collect harms as well as benefits and examine whether the combination changes tolerability.
Chemical compatibility is another question. Evidence of clinical benefit from two separately studied materials would not demonstrate that they remain suitable when mixed in a single container.
The practical answer is that the available stories generate hypotheses rather than a validated combination plan. This article provides no stacking instructions, mixing advice or recommendations about devices. The evidence needed is a direct comparison of the actual proposed combination, not a collection of favorable accounts about its parts.